Summary
The StarTalk podcast episode titled "The COVID-19 Vaccines with Irwin Redlener" features an interview with Dr. Erwin Redliner, the founding director of Columbia University's National Center for Disaster Preparedness. The interview covers a variety of topics related to COVID-19 vaccines, including the skepticism surrounding the vaccines due to their introduction during the Trump administration, the integrity of institutions such as the CDC, and the distrust of big pharma. The conversation also touches on the historical context of the black community's mistrust of organized medicine, specifically the Tuskegee experiments.
Dr. Redliner explains that while the COVID-19 vaccines are effective in preventing serious illness and hospitalizations, it is unclear if vaccinated individuals can still spread the virus. He also discusses the different storage requirements for vaccines, with the Pfizer vaccine requiring extremely low temperatures, making it difficult to distribute in developing countries. However, the new Johnson & Johnson vaccine can be stored in a regular refrigerator for up to three months, making it a valuable tool in global efforts to combat COVID-19.
The podcast episode emphasizes the importance of both vaccines and new medications to treat the early forms of the disease in gaining control over the pandemic. The concept of herd immunity is also discussed, with the speaker explaining that a certain percentage of the population needs to either have the disease or be vaccinated to achieve it. However, the percentage required for herd immunity is higher than previously thought, around 85-90% of the population.
The podcast also touches on the issue of virus mutations and the need for continued vaccination and precautions to prevent the mutations from running wild. Finally, the speaker stresses the importance of educating people on the uncertainties and constant exploration of science, and the need to trust the scientists and the scientific process. Overall, the interview provides valuable insights into the COVID-19 vaccines and the challenges in restoring trust in institutions and vaccines.
